Pago, based in Colchester, UK, has developed a compact late-stage labelling system for applying labels and patient information leaflets to small volumes of pharmaceutical cartons off-line.
The company says Late Stage Labelling (LSL) introduces a technology that allows pharmaceutical companies to produce language-specific packs in low volumes to markets with unpredictable demand.
The system consists of an automatic thermal print and apply unit, a PAGOmat 15 E-i labelling head, linked to an automatic leaflet feeder. The leaflet is assembled to the label and both applied to a "core" carton, guided by an operator through the application process. 2D data matrix codes are read to confirm all the final pack components are in place. With sequential numbering and a tamper evidence seal each pack is unique and secure, which Pago claims is a first in general pharmaceutical distribution.
The advantages are very low volume (fewer than 10 packs), market-specific packs produced with a much faster lead time than current production, allowing new markets to be serviced efficiently and profitably. One customer's lead-time has been reduced from 14 to 4 weeks.
The company says LSL eliminates the need to rework packs to meet legislative requirements as they meet this legislation at the time of final packing.
Print and database software is Included with the system. Label text is directly controlled by customers using their artwork files to produce approved label designs. GMP quality systems have been established to audit print clarity, and report individual job and order compliance.
The company says a unique feature of the pack produced by this equipment is the secure presentation of the patient information leaflet on the outside of the pack. The detailed label design ensures that the leaflet must be removed by the patient to open the pack and hence increases the likelihood that it will be read by the patient.
